This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.

Aggerbeck et al. determined the optimal dose and specificity of recombinant ESAT-6 and CFP-10 (C-TB) produced in Lactococcus lactis for diagnosis of M. tuberculosis infection. In doing so, the authors discovered that C-Tb offers a simple and convenient skin test to diagnose M.tuberculosis infection. This skin test is also unaffected by the BCG vaccination.

To read the entire article, published in PLoS ONE, click here.


Please Sign in (or Register) to view further.